[{"indications": "Indications\u00a0mild to moderate pain, pyrexia; antiplatelet (section 2.9)", "name": "ASPIRIN With metoclopramide", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.7 Analgesics", "4.7.1 Non-opioid analgesics and compound analgesic preparations", "ASPIRIN", "With metoclopramide"], "cautions": "Cautions\u00a0asthma, allergic\r\ndisease, dehydration; preferably avoid during fever or viral infection\r\nin children (risk of Reye\u2019s syndrome, see below); elderly; G6PD-deficiency (section 9.1.5); concomitant use of drugs that\r\nincrease risk of bleeding; anaemia; thyrotoxicosis; interactions: Appendix 1 (aspirin)", "side-effects": "Side-effects\u00a0generally mild and infrequent but high incidence\r\nof gastro-intestinal irritation with slight asymptomatic blood loss,\r\nblood disorders have occurred (including increased bleeding time),\r\nconfusion, tinnitus, bronchospasm and skin reactions in hypersensitive\r\npatients. Prolonged administration, see section 10.1.1. Overdosage: see Emergency Treatment of Poisoning", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/85425.htm", "doses": ["By mouth, 300\u2013900\u00a0mg every 4\u20136 hours when\r\nnecessary; max. 4\u00a0g daily; child under\r\n16 years not recommended (see Reye\u2019s Syndrome, above)", "By rectum, 450\u2013900\u00a0mg every 4 hours (max. 3.6\u00a0g\r\ndaily); child under 16 years not recommended\r\n(see Reye\u2019s Syndrome, above)", "Name[MigraMax\u00ae (Winthrop) ] Oral powder, lemon flavour, aspirin\r\n(as lysine acetylsalicylate) 900\u00a0mg, metoclopramide hydrochloride 10\u00a0mg/sachet, net price 6-sachet pack = \u00a36.61, 20-sachet pack =\r\n\u00a322.01. \r\n    Label:\r\n    13, 21, 32Dose\u00a0acute migraine, adult over\r\n20 years 1 sachet in water at onset of attack, repeated after 2 hours\r\nif necessary (max. 3 sachets in 24 hours); adult under 20 years and child not recommendedImportant\u00a0Metoclopramide can cause severe extrapyramidal effects, particularly in children\r\nand young adults (for further details, see Metoclopramide)Note\u00a0Treatment should not exceed\r\n3 months due to risk of tardive dyskinesiaExcipients  include aspartame (section 9.4.1)"], "pregnancy": "Pregnancy\u00a0high doses may be related to intrauterine growth\r\nrestriction and teratogenic effects; impaired platelet function with\r\nrisk of haemorrhage, and delayed onset and increased duration of labour\r\nwith increased blood loss, can occur if used during delivery; avoid\r\nanalgesic doses if possible in last few weeks (low doses probably\r\nnot harmful); with high doses, closure of fetal ductus arteriosus\r\nin utero and possibly persistent pulmonary hypertension of newborn;\r\nkernicterus in jaundiced neonates"}, {"indications": "Indications\u00a0mild to moderate pain, pyrexia; antiplatelet (section 2.9)", "name": "ASPIRIN With codeine phosphate 8\u00a0mg", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.7 Analgesics", "4.7.1 Non-opioid analgesics and compound analgesic preparations", "ASPIRIN", "With codeine phosphate 8\u00a0mg"], "cautions": "Cautions\u00a0asthma, allergic\r\ndisease, dehydration; preferably avoid during fever or viral infection\r\nin children (risk of Reye\u2019s syndrome, see below); elderly; G6PD-deficiency (section 9.1.5); concomitant use of drugs that\r\nincrease risk of bleeding; anaemia; thyrotoxicosis; interactions: Appendix 1 (aspirin)", "side-effects": "Side-effects\u00a0generally mild and infrequent but high incidence\r\nof gastro-intestinal irritation with slight asymptomatic blood loss,\r\nblood disorders have occurred (including increased bleeding time),\r\nconfusion, tinnitus, bronchospasm and skin reactions in hypersensitive\r\npatients. Prolonged administration, see section 10.1.1. Overdosage: see Emergency Treatment of Poisoning", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3463.htm", "doses": ["By mouth, 300\u2013900\u00a0mg every 4\u20136 hours when\r\nnecessary; max. 4\u00a0g daily; child under\r\n16 years not recommended (see Reye\u2019s Syndrome, above)", "By rectum, 450\u2013900\u00a0mg every 4 hours (max. 3.6\u00a0g\r\ndaily); child under 16 years not recommended\r\n(see Reye\u2019s Syndrome, above)", "Name[(1)Co-codaprin (Non-proprietary) ] Dispersible tablets, co-codaprin\r\n8/400 (codeine phosphate 8\u00a0mg, aspirin 400\u00a0mg), net price 100-tab pack = \u00a342.03. \r\n    Label:\r\n    13, 21, 32Dose\u00a01\u20132 tablets in water every 4\u20136 hours; max. 8 tablets dailyWhen co-codaprin tablets or dispersible tablets\r\nare prescribed and no strength is stated, tablets or dispersible tablets,\r\nrespectively, containing codeine phosphate 8\u00a0mg\r\nand aspirin 400\u00a0mg should be dispensed"], "pregnancy": "Pregnancy\u00a0high doses may be related to intrauterine growth\r\nrestriction and teratogenic effects; impaired platelet function with\r\nrisk of haemorrhage, and delayed onset and increased duration of labour\r\nwith increased blood loss, can occur if used during delivery; avoid\r\nanalgesic doses if possible in last few weeks (low doses probably\r\nnot harmful); with high doses, closure of fetal ductus arteriosus\r\nin utero and possibly persistent pulmonary hypertension of newborn;\r\nkernicterus in jaundiced neonates"}, {"indications": "Indications\u00a0secondary prevention of thrombotic cerebrovascular\r\nor cardiovascular disease, and following by-pass surgery (see also section 2.10.1 and notes above)", "name": "ASPIRIN (antiplatelet)", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "2 Cardiovascular system", "2.9 Antiplatelet drugs"], "cautions": "Cautions\u00a0asthma; uncontrolled\r\nhypertension; previous peptic ulceration (but manufacturers may advise avoidance of low-dose aspirin in history of peptic ulceration); concomitant use of\r\ndrugs that increase risk of bleeding; G6PD\r\ndeficiency (section 9.1.5); dehydration; elderly; interactions: Appendix 1 (aspirin)", "side-effects": "Side-effects\u00a0bronchospasm; gastro-intestinal irritation, gastro-intestinal\r\nhaemorrhage (occasionally major), also other haemorrhage (e.g. subconjunctival)", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/2803.htm", "doses": ["See notes above"], "pregnancy": "Pregnancy\u00a0use with caution during third trimester; impaired\r\nplatelet function and risk of haemorrhage; delayed onset and increased\r\nduration of labour with increased blood loss; avoid analgesic doses\r\nif possible in last few weeks (low doses probably not harmful); with\r\nhigh doses, closure of fetal ductus arteriosus in utero and possibly persistent pulmonary hypertension of newborn; kernicterus\r\nin jaundiced neonates"}, {"indications": "Indications\u00a0mild to moderate pain, pyrexia; antiplatelet (section 2.9)", "name": "ASPIRIN", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "4 Central nervous system", "4.7 Analgesics", "4.7.1 Non-opioid analgesics and compound analgesic preparations", "ASPIRIN"], "cautions": "Cautions\u00a0asthma, allergic\r\ndisease, dehydration; preferably avoid during fever or viral infection\r\nin children (risk of Reye\u2019s syndrome, see below); elderly; G6PD-deficiency (section 9.1.5); concomitant use of drugs that\r\nincrease risk of bleeding; anaemia; thyrotoxicosis; interactions: Appendix 1 (aspirin)", "side-effects": "Side-effects\u00a0generally mild and infrequent but high incidence\r\nof gastro-intestinal irritation with slight asymptomatic blood loss,\r\nblood disorders have occurred (including increased bleeding time),\r\nconfusion, tinnitus, bronchospasm and skin reactions in hypersensitive\r\npatients. Prolonged administration, see section 10.1.1. Overdosage: see Emergency Treatment of Poisoning", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3462.htm", "doses": ["By mouth, 300\u2013900\u00a0mg every 4\u20136 hours when\r\nnecessary; max. 4\u00a0g daily; child under\r\n16 years not recommended (see Reye\u2019s Syndrome, above)", "By rectum, 450\u2013900\u00a0mg every 4 hours (max. 3.6\u00a0g\r\ndaily); child under 16 years not recommended\r\n(see Reye\u2019s Syndrome, above)"], "pregnancy": "Pregnancy\u00a0high doses may be related to intrauterine growth\r\nrestriction and teratogenic effects; impaired platelet function with\r\nrisk of haemorrhage, and delayed onset and increased duration of labour\r\nwith increased blood loss, can occur if used during delivery; avoid\r\nanalgesic doses if possible in last few weeks (low doses probably\r\nnot harmful); with high doses, closure of fetal ductus arteriosus\r\nin utero and possibly persistent pulmonary hypertension of newborn;\r\nkernicterus in jaundiced neonates"}]